According to the expression of estrogen receptor (ERα), progesterone receptor (PR), and human epidermal growth factor receptor (HER2), breast cancer is divided into ER/PR-positive, HER2-positive, and triple-negative breast cancer (TNBC) (Sotiriou and Pusztai, 2009). This evidence concerns the gene ERBB2 and breast cancer.